ARCHIVES

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

This article is from The Cancer Letter archive.

Vol. 20 No. 13 | April 1, 1994

Download PDF Visit The Full Archive

Related Articles

AMA Supports Right To Silicone Implants, Kessler Takes Issues

December 3, 1993

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009